NLRP3 and Hepatic fibrosis: Several researchers pointed out that NLRP3 inflammsome deficiency has a protective effect against carbon tetrachloride (CCl4) or thioacetamide (TAA)-induced liver fibrosis, and that it reduces mortality and liver injury after acetaminophen administration [57, 58].